Global Health Systems Are Learning To Embrace AI As A Force For Good

AI Is Increasingly Seen As A Realistic Solution To The Demand Overload On Clinicians

The term artificial intelligence was coined at the Dartmouth Summer Research Project in 1956, but it is only in very recent years that it has been consistently at the top of the agenda in discussions on the future direction of health care. As a tool to improve both the quality and speed of care, AI is now increasingly seen as a realistic solution to the demand overload on clinicians. At the same time, techno-fears are abating. This confluence will transform health care radically in the next two decades.

Big data and artificial intelligence concept. Machine learning and cyber mind domination concept in form of women face outline outline with circuit board and binary data flow on blue background. - Vector
• Source: Shutterstock

“AI will change the world of health care.” So said Siemens Healthineers AG CFO Jochen Schmitz, addressing a room full of investors at the Jefferies Global Healthcare Conference in November 2019. The IVDs and imaging group had posted annual 2018-2019 groups sales up 5.8% that same month, and Schmitz was looking ahead to future reporting periods when AI would be having a clear and identifiable influence on revenues. “The health care industry can and will benefit from digital and AI, and imaging and radiology are the clear and obvious doors of entry for AI,” he said.

The requirement for support for physicians during radiological routines is compelling: with more patients needing more examinations and CT images, clinical staff are prone to being overloaded, and tight turnaround times and fatigue can lead to anomalies being overlooked. Artificial – or augmented ̶ intelligence, on the other hand, works at a constant level of performance

AI Defined

Just as there is no single definition of what digital health care comprises, so the parameters for artificial intelligence are difficult to establish. In its recent “AI in Life Sciences” compilation, law and tax firm CMS suggests that, for a program to claim AI capability, it should demonstrate behaviors associated with human intelligence, such as planning, learning, reasoning, problem-solving, knowledge representation, perception, motion and manipulation

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Outlook Archive

More from Outlook

Investor Optimism Ahead As Big Medtech Proves ‘It’s All About Value’

 
• By 

Pressure to exploit connected care functionality is accelerating the shift in care delivery away from the inpatient setting. Medtechs are reshaping to maximize faster-growth opportunities.

2024’s Busiest Dealmakers: Novartis Laps The Field, While Lilly, Sanofi Keep Busy

 
• By 

Nine biopharma companies made 12 or more deals, with Novartis inking 21 deals and leading M&A activity. Roche, meanwhile, spent little up front but maintained a hectic pace with 12 alliances.

Big Pharma Headcounts: Obesity Leaders Bulk Up As Others Go Lean

 

As Eli Lilly and Novo Nordisk reap the blockbuster rewards of their rival obesity therapies the companies are also bulking up their organizations to make the most of the phenomenal rise of the GLP-1 class.